Filing Details

Accession Number:
0001209191-17-044425
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-07-07 17:02:00
Reporting Period:
2017-07-05
Filing Date:
2017-07-07
Accepted Time:
2017-07-07 17:02:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879169 Incyte Corp INCY Services-Commercial Physical & Biological Research (8731) 943136539
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1642041 Paul Trower 1801 Augustine Cut-Off
Wilmington DE 19803
Principal Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-07-05 1,198 $0.00 12,148 No 4 A Direct
Common Stock Acquisiton 2017-07-05 3,000 $17.79 15,148 No 4 M Direct
Common Stock Disposition 2017-07-05 3,000 $126.18 12,148 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Acquisiton 2017-07-05 2,539 $0.00 2,539 $128.34
Common Stock Incentive Stock Option (right to buy) Acquisiton 2017-07-05 216 $0.00 216 $128.34
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2017-07-05 3,000 $0.00 3,000 $17.79
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,539 2027-07-04 No 4 A Direct
216 2027-07-04 No 4 A Direct
25,187 2019-01-18 No 4 M Direct
Footnotes
  1. Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Mr. Trower's continued service with the Issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
  2. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
  3. Represents weighted average sale price. Actual sale prices ranged from $125.47 - $126.76.
  4. Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
  5. Includes an aggregate of 4,380 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
  6. Beginning July 5, 2017, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
  7. Beginning January 19, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.